Announcements and Notices - [Inside Information / Other - Trading Update] CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2020
Announcements and Notices - [Other - Business Update] CHANGE IN USE OF NET PROCEEDS FROM THE GLOBAL OFFERING
Announcements and Notices - [Change in Chief Executive / Change in Directors or of Important Executive Functions or Responsibilities] APPOINTMENT OF VICE CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER AND CHANGE OF AUTHORISED REPRESENTATIVE
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR BEVACIZUMAB INJECTION (TAB008, A BIOSIMILAR TO AVASTIN) BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Announcements and Notices - [Results of EGM/SGM] POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 21 AUGUST 2020
Announcements and Notices - [Interim Results] INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2020
Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
Announcements and Notices - [Notice of EGM/SGM] NOTICE OF EXTRAORDINARY GENERAL MEETING
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - COMPLETION OF DOSING IN THE FIRST PATIENT FOR THE PHASE III CLINICAL TRIAL OF TAA013, AN ANTIBODY DRUG CONJUGATE
Announcements and Notices - [Results of AGM] POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 24 JUNE 2020
Announcements and Notices - [Issue of Shares under a Specific Mandate / Connected Transaction / Other - Miscellaneous] (1) ADOPTION OF RESTRICTED SHARE AWARD SCHEME (2) GRANT OF AWARD SHARES UNDER THE SCHEME (3) CONNECTED TRANSACTION INVOLVING ISSUE OF NEW SHARES TO TRUSTEE HOLDING SHARES ON TRUST FOR CERTAIN DIRECTORS
Announcements and Notices - [Notice of AGM] NOTICE OF ANNUAL GENERAL MEETING
Announcements and Notices - [Inside Information / Other - Trading Update] CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2020
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities] APPOINTMENT OF CHIEF OPERATING OFFICER
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - MEETING OF PRIMARY ENDPOINT IN PHASE III CLINICAL TRIAL OF TAB008
Announcements and Notices - [Final Results] ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2019
Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - LISTING OF CLINICAL RESEARCH AND COMMERCIALIZATION PROJECT IN RELATION TO TAB014 AS A SPECIAL MAJOR PROJECT FOR TECHNOLOGIES OF INNOVATIVE MANUFACTURING OF MAJOR NEW DRUGS IN CHINA